No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome

BACKGROUND: Despite the availability of high-sensitive troponin (hs-cTnT), there is still room for improvement in the diagnostic assessment of patients suspected of acute coronary syndrome (ACS). Apart from serial biomarker testing, which is time-consuming, novel biomarkers like copeptin have been p...

Descripción completa

Detalles Bibliográficos
Autores principales: Poldervaart, Judith M., Röttger, Emma, Dekker, Marieke S., Zuithoff, Nicolaas P. A., Verheggen, Peter W. H. M., de Vrey, Evelyn A., Wildbergh, Thierry X., van ‘t Hof, Arnoud W. J., Mosterd, Arend, Hoes, Arno W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503345/
https://www.ncbi.nlm.nih.gov/pubmed/26177390
http://dx.doi.org/10.1371/journal.pone.0132000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503345/
https://www.ncbi.nlm.nih.gov/pubmed/26177390
http://dx.doi.org/10.1371/journal.pone.0132000

Ejemplares similares